| 000 | 01165 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250514054542.0 | ||
| 264 | 0 | _c20030326 | |
| 008 | 200303s 0 0 eng d | ||
| 022 | _a1354-3784 | ||
| 024 | 7 |
_a10.1517/13543784.12.1.51 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLaird, A Douglas | |
| 245 | 0 | 0 |
_aSmall molecule tyrosine kinase inhibitors: clinical development of anticancer agents. _h[electronic resource] |
| 260 |
_bExpert opinion on investigational drugs _cJan 2003 |
||
| 300 |
_a51-64 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xchemical synthesis |
| 650 | 0 | 4 |
_aClinical Trials as Topic _xtrends |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xchemical synthesis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aProtein-Tyrosine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aTechnology, Pharmaceutical _xmethods |
| 700 | 1 | _aCherrington, Julie M | |
| 773 | 0 |
_tExpert opinion on investigational drugs _gvol. 12 _gno. 1 _gp. 51-64 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1517/13543784.12.1.51 _zAvailable from publisher's website |
| 999 |
_c12320111 _d12320111 |
||